Preoperative prediction of early recurrence in pancreatic cancer: A novel clinical–radiomics model
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70142 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Yiting Xu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neoplasm Recurrence, Local, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, Major Research Plan of the National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Early postoperative recurrence critically impacts pancreatic ductal adenocarcinoma prognosis, yet comprehensive preoperative prediction models remain underexplored. In this two‐center retrospective study of 895 treatment‐naïve PDAC patients who underwent direct resection (training n = 567; internal validation n = 241; external validation n = 87), we defined early recurrence as tumor relapse within 6 months of surgery. We first built a clinical model using logistic regression to select clinical variables and a radiomics model by applying LASSO regression to features extracted from preoperative CT images, then combined these into an integrated clinical–radiomics model via logistic regression. Of the 895 patients (64.4% male; mean age 64.4 ± 8.7 years), 213 (23.8%) experienced early recurrence. Four clinical variables (gender, CA125, radiologic N stage, adjuvant treatment) and 29 radiomics features were selected for the final model, which achieved area under the curve values of 0.862 (95% CI 0.828–0.896) in the training cohort, 0.843 (0.785–0.901) in internal validation, and 0.848 (0.748–0.949) in external validation—each outperforming either the clinical or radiomics model alone. Stratified analyses confirmed robustness across subgroups, and patients classified as high risk by the model had significantly shorter disease‐free and overall survival (both p < .001). This clinical–radiomics model offers a preoperative tool to identify PDAC patients at high risk of early postoperative recurrence, thereby supporting personalized treatment planning beyond immediate surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- First School of Clinical Medicine, Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Tingbo Liang, Qi Zhang
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Major Research Plan of the National Natural Science Foundation of China
- National Natural Science Foundation of China
- Major Project Jointly Constructed by Science and Education Department of National Administration of Traditional Chinese Medicine and Zhejiang Provincial Admini…
- National Key Research & Development Program
Zitieren
APA
Xu, Y., Chen, M., Chen, Y., Cai, Z., Luo, Z., Wang, B., Jin, G., Wang, Y., Han, X., Xue, X., Liu, L., Liu, P., Ma, Z., Luo, H., Liang, T., & Zhang, Q. (2026). Preoperative prediction of early recurrence in pancreatic cancer: A novel clinical–radiomics model. International Journal of Cancer. https://doi.org/10.1002/ijc.70142
Vancouver
Xu Y, Chen M, Chen Y, Cai Z, Luo Z, Wang B, et al. Preoperative prediction of early recurrence in pancreatic cancer: A novel clinical–radiomics model. International Journal of Cancer. 2026. doi:10.1002/ijc.70142
BibTeX
@article{Xu2026,
author = {Xu, Yiting and Chen, Ming and Chen, Yang and Cai, Zhihang and Luo, Zongyan and Wang, Bing and Jin, Gaowei and Wang, Yangyang and Han, Xu and Xue, Xing and Liu, Liying and Liu, Pu and Ma, Zhihao and Luo, Huan and Liang, Tingbo and Zhang, Qi},
title = {Preoperative prediction of early recurrence in pancreatic cancer: A novel clinical–radiomics model},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70142}
}
EUVIMED